Hubei Hendi Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") guarantees that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
The second board of directors of Hubei Hendi Pharmaceutical Co., Ltd. is about to complete its term. According to the Company Law of the People's Republic of China, the Shenzhen Stock Exchange Growth Enterprise Market Listing Rules, and the Shenzhen Stock Exchange Self-Regulatory Guidelines No. 2 for Listed Companies on the Growth Enterprise Market, as well as relevant provisions in the Articles of Association, the Company will conduct the election of the board of directors in accordance with the relevant legal procedures.
The board of directors consists of 8 members, including 4 non-independent directors, 3 independent directors, and 1 employee representative director, who is elected by the employee representative assembly. Non-independent and independent directors are elected by the shareholders' meeting.